Vanessa Burrows, Jennifer Geetter, Daniel Gottlieb and Michael Ryan wrote this bylined article analyzing FDA draft guidance addressing cybersecurity vulnerabilities in medical devices. The authors warned that “if a device manufacturer does not take steps to remediate an uncontrolled risk that is essential to its clinical performance … the FDA will consider such devices to be in violation of the [Food Drug and Cosmetics Act] and subject to enforcement action.”
